← Back to Search

Procedure

High-density Microelectrode for Parkinson's Disease

N/A
Waitlist Available
Led By Adam Mamelak, MD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week after recording in or completed
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new electrode to measure brain nerve cells & local field potentials, to see if it works better than standard electrodes & is safe.

Who is the study for?
This trial is for adults over 18 with Parkinson's Disease who are undergoing a Deep Brain Stimulating (DBS) electrode implant in the brain to improve treatment. They must be able to consent and have no allergies to stainless steel or polyimide, nor previous DBS implants at the site.
What is being tested?
The study tests a new high-density microelectrode designed for recording individual and group nerve cell activity in the human brain. It aims to compare its performance and safety against standard electrodes during DBS procedures.
What are the potential side effects?
While specific side effects aren't listed, potential risks may include typical surgical complications related to DBS procedures such as infection, bleeding, or allergic reactions to materials used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week after recording in or completed
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week after recording in or completed for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Breakage of Electrode
Neuronal Activity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neuronal Recording and Behavioral TestingExperimental Treatment1 Intervention
Neuronal Recording and Behavioral Testing

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
512 Previous Clinical Trials
163,354 Total Patients Enrolled
Adam Mamelak, MDPrincipal InvestigatorCedars-Sinai Medical Center
3 Previous Clinical Trials
314 Total Patients Enrolled

Media Library

DBD (Diagnostic Biochips) Deep Array microelectrode (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05919160 — N/A
Parkinson's Disease Research Study Groups: Neuronal Recording and Behavioral Testing
Parkinson's Disease Clinical Trial 2023: DBD (Diagnostic Biochips) Deep Array microelectrode Highlights & Side Effects. Trial Name: NCT05919160 — N/A
DBD (Diagnostic Biochips) Deep Array microelectrode (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05919160 — N/A
~3 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top